Primary exposure to SARS-CoV-2 variants elicits convergent epitope specificities, immunoglobulin V gene usage and public B cell clones
N. S. Lima, M. Musayev, T. S. Johnston, D. A. Wagner, A. R. Henry, L. Wang, E. S. Yang, Y. Zhang, K. Birungi, W. P. Black, S. O'Dell, S. D. Schmidt, D. Moon, C. G. Lorang, B. Zhao, M. Chen, K. L. Boswell, J. Roberts-Torres, R. L. Davis, L. Peyton, S. R. Narpala, S. O'Connell, J. Wang, A. Schrager, C. A. Talana, , P. D. Kwong
Abstract
An important consequence of infection with a SARS-CoV-2 variant is protective humoral immunity against other variants. The basis for such cross-protection at the molecular level is incompletely understood. Here we characterized the repertoire and epitope specificity of antibodies elicited by Beta, Gamma and ancestral variant infection and assessed their cross-reactivity to these and the more recent Delta and Omicron variants. We developed a high-throughput approach to obtain immunoglobulin sequences and produce monoclonal antibodies for functional assessment from single B cells. Infection with any variant elicited similar cross-binding antibody responses exhibiting a remarkably conserved hierarchy of epitope immunodominance. Furthermore, convergent V gene usage and similar public B cell clones were elicited regardless of infecting variant. These convergent responses despite antigenic variation may represent a general immunological principle that accounts for the continued efficacy of vaccines based on a single ancestral variant.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies
S. M. Reincke, M. Yuan, … J. Kreye·bioRxiv·Sep 30, 2021
- Mapping SARS-CoV-2 antigenic relationships and serological responses
S. H. Wilks, B. Muhlemann, … D. J. Smith·bioRxiv·Jan 28, 2022
- Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strains
N. Faulkner, K. Ng, … G. Kassiotis·bioRxiv·Mar 1, 2021
- Vaccine imprinting drives increased SARS-CoV-2 variant infection in children
Timothy S. Johnston, Rahul Subramanian, … Daniel C. Douek·bioRxiv·Aug 17, 2026
- Ancestral SARS-CoV-2 driven antibody repertoire diversity in an unvaccinated individual correlates with expanded neutralization breadth
S. Deshpande, M. Y. Ansari, … J. Bhattacharya·bioRxiv·Oct 19, 2022
- Immunogenicity of convalescent and vaccinated sera against clinical isolates of ancestral SARS-CoV-2, beta, delta, and omicron variants
A. Banerjee, J. Lew, … D. Falzarano·bioRxiv·Jan 13, 2022